Resonant Capital Advisors’s Elanco Animal Health ELAN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $453K | Buy |
31,733
+2,319
| +8% | +$33.1K | 0.03% | 251 |
|
|
2025
Q1 | $309K | Buy |
29,414
+1,576
| +6% | +$16.5K | 0.02% | 280 |
|
|
2024
Q4 | $337K | Buy |
27,838
+266
| +1% | +$3.22K | 0.02% | 251 |
|
|
2024
Q3 | $405K | Buy |
27,572
+247
| +0.9% | +$3.63K | 0.03% | 227 |
|
|
2024
Q2 | $394K | Buy |
27,325
+1,306
| +5% | +$18.8K | 0.03% | 224 |
|
|
2024
Q1 | $424K | Buy |
26,019
+230
| +0.9% | +$3.74K | 0.04% | 217 |
|
|
2023
Q4 | $384K | Buy |
25,789
+4,172
| +19% | +$62.2K | 0.04% | 206 |
|
|
2023
Q3 | $243K | Buy |
21,617
+833
| +4% | +$9.36K | 0.03% | 241 |
|
|
2023
Q2 | $209K | Buy |
20,784
+1,028
| +5% | +$10.3K | 0.02% | 258 |
|
|
2023
Q1 | $186K | Buy |
19,756
+432
| +2% | +$4.06K | 0.02% | 248 |
|
|
2022
Q4 | $236K | Buy |
+19,324
| New | +$236K | 0.03% | 233 |
|
|
2022
Q2 | – | Sell |
-14,294
| Closed | -$373K | – | 240 |
|
|
2022
Q1 | $373K | Buy |
14,294
+614
| +4% | +$16K | 0.06% | 165 |
|
|
2021
Q4 | $388K | Buy |
13,680
+1,174
| +9% | +$33.3K | 0.06% | 153 |
|
|
2021
Q3 | $399K | Buy |
12,506
+2,266
| +22% | +$72.3K | 0.07% | 145 |
|
|
2021
Q2 | $355K | Buy |
10,240
+275
| +3% | +$9.53K | 0.07% | 143 |
|
|
2021
Q1 | $293K | Buy |
9,965
+130
| +1% | +$3.82K | 0.06% | 151 |
|
|
2020
Q4 | $302K | Buy |
9,835
+422
| +4% | +$13K | 0.07% | 149 |
|
|
2020
Q3 | $263K | Sell |
9,413
-1,530
| -14% | -$42.7K | 0.08% | 138 |
|
|
2020
Q2 | $235K | Sell |
10,943
-5,534
| -34% | -$119K | 0.07% | 163 |
|
|
2020
Q1 | $369K | Buy |
16,477
+1,096
| +7% | +$24.5K | 0.13% | 147 |
|
|
2019
Q4 | $453K | Buy |
+15,381
| New | +$453K | 0.14% | 152 |
|